| Safety and Efficacy Study of NGGT002 in Adult Patients With Phenylketonuria (NCT06687733) | NGGT (Suzhou) Biotechnology Co., Ltd. | 2024-07-16 |
| Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119 (NCT06504290) | Vigonvita Life Sciences | 2024-07-16 |
| A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease. (NCT06466525) | Longevity Biotech Australia Pty Ltd (subsidiary) | 2024-07-16 |
| A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy Participants (NCT06503679) | DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company | 2024-07-16 |
| A Study to Compare Oral Formulations of Tedizolid Phosphate in Healthy Adults (MK-1986-044) (NCT06609161) | Merck Sharp & Dohme LLC | 2024-07-16 |
| A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors (NCT06487858) | BeOne Medicines | 2024-07-16 |
| Biomechanical Analysis of Distal Radius (Greenstick) Fracture Healing (NCT06510595) | Cairo University | 2024-07-16 |
| Desogestrel Tablets (0.075 mg) Relative to Originator Desogestrel Tablets (0.075 mg) (NCT06233084) | Bio-innova Co., Ltd | 2024-07-16 |
| Inhaled Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Post-Infectious Cough: A Single-Center Randomized Controlled Clinical Trial (NCT07103980) | Shanghai Changzheng Hospital | 2024-07-16 |
| Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies (NCT06466798) | Jeffrey Treiber | 2024-07-15 |
| Treating Stress and Anxiety in Individuals With Alcohol Use Disorder (AUD) (NCT06224127) | Soovu Labs Inc. | 2024-07-15 |
| Comparison of the Efficacy of Diclofenac Sodium and Subcutaneous 5% Dextrose Injection in Low Back Pain. (NCT06829030) | Aksaray University Training and Research Hospital | 2024-07-15 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled AZD4604 in Healthy Japanese and Chinese Participants. (NCT06519968) | AstraZeneca | 2024-07-15 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy Participants (NCT06491550) | AstraZeneca | 2024-07-15 |
| Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients (NCT06416436) | University of Kansas Medical Center | 2024-07-15 |
| Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human (NCT06495931) | Shandong Suncadia Medicine Co., Ltd. | 2024-07-15 |
| An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation. (NCT06511791) | Ferring Pharmaceuticals | 2024-07-15 |
| Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years (NCT06409494) | EuBiologics Co.,Ltd | 2024-07-15 |
| A Study to Investigate the Effects of Zelicapavir (EDP-938) on QTc Interval in Healthy Adults (NCT06601192) | Enanta Pharmaceuticals, Inc | 2024-07-15 |
| Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges (NCT06445374) | Dr. George Luciuk | 2024-07-15 |
| Estradiol Plus Olaparib for Breast Cancer (PHOEBE) (NCT05900895) | Mary D Chamberlin | 2024-07-15 |
| A Clinical Trial to Evaluate Bioavailability and Effect of Food for Sotorasib in Healthy Participants (NCT06061523) | Amgen | 2024-07-15 |
| TTAX03 for the Treatment of Lumbosacral Facet Joint Pain (NCT06236308) | BioTissue Holdings, Inc | 2024-07-15 |
| Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia (NCT05700630) | Masonic Cancer Center, University of Minnesota | 2024-07-15 |
| A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tumors (MK-6837-001) (NCT06460961) | Merck Sharp & Dohme LLC | 2024-07-14 |
| Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution (NCT07105371) | The Foundation for Orthopaedics and Regenerative Medicine | 2024-07-14 |
| Safety and Tolerability of IBI355 in Patients With Primary Sjogren's Syndrome (NCT06484855) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-07-14 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects (NCT06427590) | Ascletis Pharma (China) Co., Limited | 2024-07-13 |
| A Study to Evaluate the Effect of Povorcitinib on the QT/QTc Interval in Healthy Participants (NCT06441318) | Incyte Corporation | 2024-07-12 |
| Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of Age (NCT06546423) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-07-12 |
| Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis (NCT06371040) | Ting Chang, MD | 2024-07-12 |
| Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis (NCT06485505) | Zagazig University | 2024-07-12 |
| Safety, Pharmacokinetics, and Plasmodium Falciparum Transmission-reducing Activity of Monoclonal Antibody TB31F in Mali (NCT06413108) | Radboud University Medical Center | 2024-07-12 |
| A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies (NCT05209295) | Bristol-Myers Squibb | 2024-07-12 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers (NCT06482190) | Shenzhen Resproly Biopharmaceutical Co., Ltd | 2024-07-11 |
| Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors (NCT06500819) | Stanford University | 2024-07-11 |
| Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab (NCT06287229) | M.D. Anderson Cancer Center | 2024-07-11 |
| A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011) (NCT06554639) | Merck Sharp & Dohme LLC | 2024-07-11 |
| A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment (NCT06562114) | Merry Life Biomedical Co., Ltd. | 2024-07-11 |
| Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency (NCT06340685) | Jirair Krikor Bedoyan | 2024-07-11 |
| Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (NCT06342986) | Masonic Cancer Center, University of Minnesota | 2024-07-11 |
| Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops (NCT06263998) | Huons Co., Ltd. | 2024-07-11 |
| Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions (NCT06494397) | Vanda Pharmaceuticals | 2024-07-11 |
| Phase I/II Study of IPG1094 in Advanced Solid Tumors Patients (NCT06212076) | Nanjing Immunophage Biotech Co., Ltd | 2024-07-11 |
| Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer (NCT06439888) | Gustave Roussy, Cancer Campus, Grand Paris | 2024-07-11 |
| Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC (NCT06681688) | Inder Paul Singh, M.D. | 2024-07-10 |
| The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles (NCT05602649) | Johns Hopkins University | 2024-07-10 |
| Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients (NCT06650332) | Zhejiang Cancer Hospital | 2024-07-10 |
| Mechanisms of Semaglutide Therapy in Heart Failure Patients (NCT06541509) | University Medical Centre Ljubljana | 2024-07-10 |
| Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM (NCT06630624) | M.R. Meijerink | 2024-07-10 |
| Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells (NCT06420076) | Essen Biotech | 2024-07-10 |
| Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML (NCT06420063) | Essen Biotech | 2024-07-10 |
| Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL). (NCT06213636) | Essen Biotech | 2024-07-10 |
| Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer (NCT06208657) | Australian & New Zealand Children's Haematology/Oncology Group | 2024-07-10 |
| Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis (NCT06324812) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2024-07-10 |
| Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) (NCT06350110) | Essen Biotech | 2024-07-10 |
| A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors (NCT06046742) | Guangzhou Virotech Pharmaceutical Co., Ltd. | 2024-07-10 |
| First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133 (NCT06290557) | University Hospital Tuebingen | 2024-07-10 |
| A First-in-Human Safety Trial of MTX-474 (NCT06535841) | Mediar Therapeutics | 2024-07-10 |
| To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects (NCT06473948) | Jemincare | 2024-07-10 |
| Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II (NCT06392009) | GRIN Therapeutics, Inc. | 2024-07-10 |
| A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors (NCT06515613) | Context Therapeutics Inc. | 2024-07-10 |
| Lenvatinib Treatment in Waiting List of Liver Transplantation After TACE Failure in Patients With Hepatocellular Carcinoma (NCT05901194) | Assistance Publique - Hôpitaux de Paris | 2024-07-10 |
| A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations (NCT06500676) | Genfleet Therapeutics (Shanghai) Inc. | 2024-07-09 |
| Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease (NCT06546995) | Neumora Therapeutics, Inc. | 2024-07-09 |
| Polyspecific Antibodies in Lymphoproliferative T-cell Disorders (NCT06495723) | Xenothera SAS | 2024-07-09 |
| Nebivolol Tablets 5 mg Relative to Nebilet Tablets 5 mg (NCT06248099) | Bio-innova Co., Ltd | 2024-07-09 |
| A Study to Investigate the Effect of Food on Camlipixant Concentrations in Healthy Participants (NCT06497517) | Bellus Health Inc. - a GSK company | 2024-07-09 |
| A Study to Investigate the Safety and Tolerability of TE-8105 in Overweight/Obese Participants Without Diabetes (NCT06471530) | Immunwork, Inc. | 2024-07-09 |
| A Study to Assess Relative Bioavailability and Food Effect of ABBV-668 Extended-Release Formulations in Adult Participants (NCT06477926) | AbbVie | 2024-07-09 |
| A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer (NCT06380816) | Cancer Research UK | 2024-07-09 |
| A First-in-Human Study of BGB-C354 Alone and in Combination With Tislelizumab in Participants With Advanced Solid Tumors (NCT06422520) | BeOne Medicines | 2024-07-08 |
| A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma (NCT06392477) | Sanofi | 2024-07-08 |
| TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies (NCT06484816) | Shenzhen TargetRx Co., Ltd. | 2024-07-08 |
| A Study of Levothyroxine and Enlicitide Decanoate (MK-0616) in Healthy Adult Participants (MK-0616-028) (NCT06625814) | Merck Sharp & Dohme LLC | 2024-07-08 |
| Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors (NCT06501183) | Shanghai Pudong Hospital | 2024-07-08 |
| A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated (NCT06429137) | Boehringer Ingelheim | 2024-07-08 |
| A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer (NCT06046495) | Avistone Biotechnology Co., Ltd. | 2024-07-08 |
| Safety and Feasibility of Hyperkalemic Cardioplegia With Diazoxide in Cardiac Surgery (CPG-DZX) Trial (NCT06308107) | Johns Hopkins University | 2024-07-08 |
| Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection (NCT06450990) | NEXBIOME THERAPEUTICS | 2024-07-08 |
| Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects (NCT06592300) | Humanis Saglık Anonim Sirketi | 2024-07-06 |
| A Clinical Study Evaluating LY-M001 Injection in the Treatment of Adult Patients With Type I Gaucher Disease (NCT06818838) | Lingyi Biotech Co., Ltd. | 2024-07-05 |
| A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation (NCT06385678) | Jiangsu HengRui Medicine Co., Ltd. | 2024-07-05 |
| A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer (NCT06508216) | Gustave Roussy, Cancer Campus, Grand Paris | 2024-07-05 |
| A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants (NCT06375512) | Shenzhen Shenxin Biotechnology Co., Ltd | 2024-07-05 |
| Safety, Tolerability, and Pharmacokinetics of FHND1002 Granules in Healthy Adults (NCT06782958) | Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | 2024-07-05 |
| Open Label , Randomized, Three Arm Parallel Group Single Dose Comparative Pharmacokinetic , Safety and Immunogenicity Study in Healthy Subjects (NCT06929039) | Kashiv BioSciences, LLC | 2024-07-04 |
| To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers (NCT06492655) | Chong Kun Dang Pharmaceutical | 2024-07-04 |
| A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants (NCT06487845) | Bayer | 2024-07-04 |
| Phase 1 Open-label Study of 123I-ATT001 in Subjects With Relapsed Glioblastoma (NCT06650605) | Theragnostics Ltd | 2024-07-04 |
| A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer (NCT06526832) | BioSyngen Pte Ltd | 2024-07-04 |
| A Study of SKB518 in Patients With Advanced Solid Tumors (NCT06428331) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2024-07-04 |
| Affect of Duavive on Mood & Anxiety Symptoms (NCT04478305) | St. Joseph's Healthcare Hamilton | 2024-07-03 |
| Proprioceptive Training Reduces Headache Burden and Center of Pressure Path Length in Patients With Cervicogenic Headache (NCT07271004) | Hungarian University of Sports Science | 2024-07-03 |
| Repurposing Lithium for Parkinson's Disease: a RCT (NCT06339034) | State University of New York at Buffalo | 2024-07-03 |
| A Study to Learn How Different Forms of The Study Medicine Called Phenytoin Are Taken up Into the Blood in Healthy Adults (NCT06466473) | Pfizer | 2024-07-03 |
| Bioavailability Study of Magne-B6 New Formulation (NCT06386211) | Opella Healthcare Group SAS, a Sanofi Company | 2024-07-03 |
| A Study of FZ-AD005 in Patients With Advanced Solid Tumors (NCT06424665) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2024-07-03 |
| Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer (NCT06464965) | Zhejiang Provincial People's Hospital | 2024-07-03 |
| Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment (NCT06547502) | Gan and Lee Pharmaceuticals, USA | 2024-07-03 |